FDA Whistleblower to Air New Pain Drug Analysis
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.
17230
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis
404405
Dr. Steven Galson, acting director of the Food and Drug Administration&#39;s Center for Drug Evaluation, announced Friday that the FDA will review five popular drugs whose safety is being questioned.
352430
US Senator Christopher Dodd will propose legislation to create an office of patient protection reporting directly to the commissioner of the Food and Drug Administration, a move to bolster the safety of prescription drugs after a torrent of worrisome announcements about painkillers and antidepressants eroded consumer confidence.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
444527
Science writer Cheryl Lyn Dybas will be online to answer questions about the discovery of a plant that contains a powerful anti-inflammatory substance.
675666
WASHINGTON -- After months of heightened concerns about the safety and effectiveness of Vioxx and similar best-selling painkillers, and intense criticism of how the Food and Drug Administration has handled them, the agency will launch critical meetings beginning tomorrow on what to do next.
129855
Dr. David Graham, the Food and Drug Administration scientist who publicly criticized the agency&#39;s approach to drug safety during a congressional hearing last week, said
150048
The Food and Drug Administration will establish a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they're on the market and update physicians and patients with emerging information on risks and benefits.
175503
In devastating testimony before a Senate panel yesterday, a whistle-blower at the Food and Drug Administration shocked a packed hearing room when he listed five drugs now on
109195
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s withdrawn arthritis pill Vioxx.
476114
WASHINGTON - The FDA scientist who studied the safety of the recalled painkiller Vioxx delivered a bombshell Thursday, naming five more drugs he believes could be dangerous.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
306400
Less than a week after two sets of new data raised questions about the cardiovascular safety of two widely used painkillers, the Pfizer Inc.
54816
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s MRK.N withdrawn arthritis pill Vioxx.
420782
A US Food and Drug Administration reviewer who criticized the agency&#39;s handling of Merck &amp; Co. Inc.&#39;s now-withdrawn Vioxx painkiller may be forced to another position
131481
Nov. 5, 2004 -- FDA officials announced Friday that they will launch a review of the agency&#39;s drug monitoring policies in the wake of recent high-profile safety concerns about widely used drugs, including antidepressants and Vioxx.